Additive Dose Response Models: Defining Synergy.

Area of Science:

• Pharmacology and Toxicology
• Computational Chemistry
• Drug Discovery

Background:

• Synergy studies evaluate compound combinations for synergistic or antagonistic effects.
• High-throughput screening identifies promising compound combinations based on response deviations.
• Non-interactive response models like Loewe Additivity and Bliss Independence are crucial for synergy assessment.

Purpose of the Study:

• To introduce and validate the Explicit Mean Equation, an explicit formulation of Loewe Additivity.
• To compare the performance of the Explicit Mean Equation against implicit Loewe Additivity and Bliss Independence.
• To evaluate the efficacy of synergy computation using lack-of-fit versus a parametric approach.

Main Methods:

• Development of the Explicit Mean Equation for calculating expected non-interactive responses.
• Application of the Explicit Mean Equation and traditional methods to synergy datasets.
• Quantification of synergy using the deviance between measured and expected responses (lack-of-fit).

Main Results:

• The Explicit Mean Equation demonstrates superior performance over implicit Loewe Additivity and Bliss Independence in measuring synergy.
• Calculating synergy as lack-of-fit significantly outperforms a parametric approach.
• Validation was performed on two distinct datasets of compound combinations categorized by interaction type.

Conclusions:

• The Explicit Mean Equation provides a more accurate method for assessing compound synergy.
• The lack-of-fit approach offers a robust alternative to parametric methods for synergy analysis.
• These advancements enhance the reliability of synergy screening in drug discovery and development.